GLA

gene product
GALA
This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
415 antibodies from 31 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Proteintech Group
5 antibodies
antibodies-online
124 antibodies
GeneTex
5 antibodies
Abgent
1 antibody
Novus Biologicals
28 antibodies
Invitrogen Antibodies
11 antibodies
NovoPro Bioscience Inc.
3 antibodies
Acris Antibodies GmbH
4 antibodies
Atlas Antibodies
2 antibodies
LifeSpan BioSciences, Inc.
113 antibodies
ProSci
2 antibodies
Biorbyt
18 antibodies
St John's Laboratory
2 antibodies
Bioworld Technology, Inc
1 antibody
Abnova Corporation
4 antibodies
OriGene
2 antibodies
R&D Systems
1 antibody
Aviva Systems Biology
2 antibodies
MyBioSource
5 antibodies
Creative Biolabs
22 antibodies
Sino Biological Inc.
5 antibodies
RabMAbs
3 antibodies
United States Biological
13 antibodies
Creative Diagnostics
4 antibodies
NSJ Bioreagents
1 antibody
Abbexa
13 antibodies
Sigma-Aldrich
3 antibodies
EMD Millipore
1 antibody
Leading Biology
1 antibody
RayBiotech, Inc.
1 antibody